| PDS BIOTECHNOLOGY CORP. |
| USA |
| Gesundheit |
| US70465T1079 / A2PF3F |
| EU6 (Frankfurt) |
| FRA:EU6, ETR:EU6, EU6:GR |
| - |
| https://www.pdsbiotech.co.. |
|
PDS Biotechnology Corporation is a clinical-stage biopharmaceutical company focused on developing cancer immunotherapies. The primary function of PDS Biotechnology is to harness the power of the immune system to eradicate cancer cells, leveraging its..
>Volltext.. |
| 28.74 Mio. EUR |
| 21.73 Mio. EUR |
| - |
| -27.87 Mio. EUR |
| -30.22 Mio. EUR |
| -0.71 EUR |
| 15.57 Mio. EUR |
| 22.7 Mio. EUR |
| -27.97 Mio. EUR |
| 1.97 |
| - |
| 18.38% |
| - |
| - |
| - |
| - |
| PDS BIOTECHNOLOGY, PDS BIOTECH |
| 05.04.26 |
|